big names in rad onc?

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
M

medhopeful08

Senior Member
7+ Year Member
15+ Year Member
20+ Year Member
Joined
Nov 3, 2002
Messages
285
Reaction score
0
out of curiosity -- who are some of the "big names" in the field of rad onc?
Members don't see this ad.
 
medhopeful08 said:
out of curiosity -- who are some of the "big names" in the field of rad onc?
Click to expand...
Man could you have picked a more difficult question to answer? There are so many. a few off the top of my head stillin practice (With apologies for spelling):

Ted Lawrence
Carlos Perez
Moody Wharam
Louis Constantine
Richard Stock
Dosortez
Emami
Zvi Fuchs
Steven Leibel
Nancy Tarbell
Sarah Donaldson
Jay Harris
Anthony D'Amico
Peter Mauch
Patricia Eiffel
Norm Coleman
Nora Janjan
Minesh Metha
Mark Ritter
Jim Welsh
Bruce Hafftey
Leonard Proznitz
Ted DeWeese
John Flickenger
Susan Woldon
Chao
Mendenhall
Giles McKenna
Eli Glatstein
William regine
Joel tepper
 
I'd add a few-
Paul Okunieff
Blasko
Merrick
Mack Roach
Frank Wilson
James Cox
Laurie Gaspar
 
Members don't see this ad :)
i thought of some of those last night.
Some more

Heman Suit
Mike Zelefsky
A. Zeitman
Luther Brady
Ang
Breizel
Richard Hoppe
Ted Philips
Bill Shipley
Larry Kuhn
Jay Loeffler
Lou Harrisson
Paul Harari
 
For those of us not in the know -- can we get institutions along with the names?

Thanks for your help.
 
Yeah, where are these people?

Also, where can we find the ranking of top rad onc programs? Thanks!
 
Ted Lawrence-University of Michigan (Chair)
Carlos Perez-Washington University (Past-Chair)
Moody Wharam
Louis Constantine
Richard Stock
Dosortez
Emami-Loyola (Chair)
Zvi Fuks-MSKCC
Steven Leibel-Stanford
Nancy Tarbell
Sarah Donaldson-UCSF?
Jay Harris-Harvard
Anthony D'Amico-Harvard
Peter Mauch
Patricia Eiffel-MDACC
Norm Coleman
Nora Janjan
Minesh Metha-University of Wisconsin (Chair)
Mark Ritter
Jim Welsh
Bruce Hafftey-Yale (PD)
Leonard Proznitz
Ted DeWeese-Johns Hopkins (Chair)
John Flickenger
Susan Woldon
Cliff Chao-MDACC
Mendenhall-University of Florida (Chair)
Giles McKenna
Eli Glatstein-University of Penn
William Regine-University of Maryland
Joel Tepper-UNC (Chair)
Leonard Gunderson-Mayo Clinic
Paul Okunieff-University of Rochester (PD)
Blasko
Merrick
Mack Roach
Frank Wilson
James Cox-MDACC (Chair)
Laurie Gaspar-Univeristy of Colorado (Chair)
Heman Suit
Mike Zelefsky
A. Zeitman
Luther Brady
Kian Ang-MDACC
Breizel
Richard Hoppe
Ted Philips
Bill Shipley
Larry Kuhn
Jay Loeffler
Lou Harrisson
Paul Harari-University of Wisconsin
 
Another nice thing would be to put the area of expertise for each of these pple...no time to do it now for myself...perhaps others...
 
Ted Lawrence-University of Michigan (Chair)
Carlos Perez-Washington University (Past-Chair)
Moody Wharam
Louis Constantine
Richard Stock
Dosortez
Emami-Loyola (Chair) [Head and Neck]
Zvi Fuks-MSKCC
Steven Leibel-Stanford
Nancy Tarbell
Sarah Donaldson-Stanford
Jay Harris-Harvard
Anthony D'Amico-Harvard [Prostate]
Peter Mauch
Patricia Eiffel-MDACC
Norm Coleman-NCI
Nora Janjan
Minesh Metha-University of Wisconsin (Chair)
Mark Ritter
Jim Welsh-Wisconsin
Bruce Hafftey-Yale (PD)
Leonard Proznitz
Ted DeWeese-Johns Hopkins (Chair)
John Flickenger
Susan Woldon
Cliff Chao-MDACC
Mendenhall-University of Florida (Chair)
Giles McKenna
Eli Glatstein-University of Penn
William Regine-University of Maryland
Joel Tepper-UNC (Chair)
Leonard Gunderson-Mayo Clinic
Paul Okunieff-University of Rochester (PD)
Blasko
Merrick
Mack Roach-UCSF [Prostate]
Frank Wilson
James Cox-MDACC (Chair)
Laurie Gaspar-Univeristy of Colorado (Chair)
Heman Suit
Mike Zelefsky
A. Zeitman
Luther Brady
Kian Ang-MDACC
Breizel
Richard Hoppe
Ted Philips-UCSF [Ocular Melanoma]
Bill Shipley
Larry Kuhn
Jay Loeffler-Harvard
Lou Harrisson
Paul Harari-University of Wisconsin
 
Ted Lawrence-University of Michigan (Chair)
Carlos Perez-Washington University (Past-Chair)
Moody Wharam
Louis Constantine
Richard Stock
Dosortez
Emami-Loyola (Chair) [Head and Neck]
Zvi Fuks-MSKCC
Steven Leibel-Stanford
Nancy Tarbell - Harvard
Sarah Donaldson-Stanford
Jay Harris-Harvard
Anthony D'Amico-Harvard [Prostate]
Peter Mauch
Patricia Eiffel-MDACC
Norm Coleman-NCI
Nora Janjan
Minesh Metha-University of Wisconsin (Chair)
Mark Ritter
Jim Welsh-Wisconsin
Bruce Hafftey-Yale (PD)
Leonard Proznitz - Duke (former Chair)
Ted DeWeese-Johns Hopkins (Chair)
John Flickenger
Susan Woldon
Cliff Chao-MDACC
Mendenhall-University of Florida (Chair)
Giles McKenna
Eli Glatstein-University of Penn
William Regine-University of Maryland
Joel Tepper-UNC (Chair)
Leonard Gunderson-Mayo Clinic
Paul Okunieff-University of Rochester (PD)
Blasko
Merrick
Mack Roach-UCSF [Prostate]
Frank Wilson
James Cox-MDACC (Chair)
Laurie Gaspar-Univeristy of Colorado (Chair)
Heman Suit
Mike Zelefsky
A. Zeitman
Luther Brady
Kian Ang-MDACC
Breizel
Richard Hoppe - Stanford
Ted Philips-UCSF [Ocular Melanoma]
Bill Shipley
Larry Kun - St.Judes
Jay Loeffler-Harvard
Lou Harrisson
Paul Harari-University of Wisconsin
 
CNphair said:
Ted Lawrence-University of Michigan (Chair) GI
Carlos Perez-Washington University (Past-Chair) Gyn
Moody Wharam-hopkins peds and past chair
Louis Constantine-U rochester peds
Richard Stock-Mt Sinai chair GU/Brachy.
Dosortez-was mass gen now private practice
Emami-Loyola (Chair) [Head and Neck]
Zvi Fuks-MSKCC
Steven Leibel-Stanford
Nancy Tarbell - Harvard peds
Sarah Donaldson-Stanford peds
Jay Harris-Harvard
Anthony D'Amico-Harvard GU
Peter Mauch-harvard lymphoma
Patricia Eiffel-MDACC gyne
Norm Coleman-NCI
Nora Janjan
Minesh Metha-University of Wisconsin (Chair) cns
Mark Ritter-u wisc prostate
Jim Welsh-Wisconsin lymphoma, prostate/general, Tomotherapy
Bruce Hafftey-Yale (PD) breast and abr pres
Leonard Proznitz - Duke (former Chair)
Ted DeWeese-Johns Hopkins (Chair) GU
John Flickenger-U Pitt CNS
Susan Woldon-MSKCC peds
Cliff Chao-MDACC H&N
Mendenhall-University of Florida (Chair) H&N
Giles McKenna-U Penn ret. chair
Eli Glatstein-University of Penn
William Regine-University of Maryland GI and CNS
Joel Tepper-UNC (Chair) GI
Leonard Gunderson-Mayo Clinic GI
Paul Okunieff-University of Rochester (PD) Chair
Blasko-GU/prostate brachy seattle
Merrick
Mack Roach-UCSF GU
Frank Wilson
James Cox-MDACC (Chair)
Laurie Gaspar-Univeristy of Colorado (Chair)
Heman Suit-name speaks for itself. ex chair Mas Gen
Mike Zelefsky-GU
A. Zeitman-GU Harvard
Luther Brady
Kian Ang-MDACC H&N
Breizel-H&N
Richard Hoppe - Stanford Lymphoma
Ted Philips-UCSF [Ocular Melanoma]
Bill Shipley-GU Mass Gen
Larry Kun - St.Judes Peds (by definition)
Jay Loeffler-Harvard CNS (benign/protons)
Lou Harrisson
Paul Harari-University of Wisconsin H&N
Phillip Devlin- Harvard Brachytherapy
Akila Viswanathan-Harvard Gyn/Brachy
Click to expand...
 
many people who are not Chairs are simply as good or better than the Chairs.

radon90


stephew said:
CNphair said:
Ted Lawrence-University of Michigan (Chair) GI
Carlos Perez-Washington University (Past-Chair) Gyn
Moody Wharam-hopkins peds and past chair
Louis Constantine-U rochester peds
Richard Stock-Mt Sinai chair GU/Brachy.
Dosortez-was mass gen now private practice
Emami-Loyola (Chair) [Head and Neck]
Zvi Fuks-MSKCC
Steven Leibel-Stanford
Nancy Tarbell - Harvard peds
Sarah Donaldson-Stanford peds
Jay Harris-Harvard
Anthony D'Amico-Harvard GU
Peter Mauch-harvard lymphoma
Patricia Eiffel-MDACC gyne
Norm Coleman-NCI
Nora Janjan
Minesh Metha-University of Wisconsin (Chair) cns
Mark Ritter-u wisc prostate
Jim Welsh-Wisconsin lymphoma, prostate/general, Tomotherapy
Bruce Hafftey-Yale (PD) breast and abr pres
Leonard Proznitz - Duke (former Chair)
Ted DeWeese-Johns Hopkins (Chair) GU
John Flickenger-U Pitt CNS
Susan Woldon-MSKCC peds
Cliff Chao-MDACC H&N
Mendenhall-University of Florida (Chair) H&N
Giles McKenna-U Penn ret. chair
Eli Glatstein-University of Penn
William Regine-University of Maryland GI and CNS
Joel Tepper-UNC (Chair) GI
Leonard Gunderson-Mayo Clinic GI
Paul Okunieff-University of Rochester (PD) Chair
Blasko-GU/prostate brachy seattle
Merrick
Mack Roach-UCSF GU
Frank Wilson
James Cox-MDACC (Chair)
Laurie Gaspar-Univeristy of Colorado (Chair)
Heman Suit-name speaks for itself. ex chair Mas Gen
Mike Zelefsky-GU
A. Zeitman-GU Harvard
Luther Brady
Kian Ang-MDACC H&N
Breizel-H&N
Richard Hoppe - Stanford Lymphoma
Ted Philips-UCSF [Ocular Melanoma]
Bill Shipley-GU Mass Gen
Larry Kun - St.Judes Peds (by definition)
Jay Loeffler-Harvard CNS (benign/protons)
Lou Harrisson
Paul Harari-University of Wisconsin H&N
Phillip Devlin- Harvard Brachytherapy
Akila Viswanathan-Harvard Gyn/Brachy
Click to expand...
Click to expand...
 
Much too high overrepresentation of Chairs as well as faculty at big name programs who have nothing behind their CV other than title or affiliation with a big name program.

Try looking at editors of major textbooks, IJROBP, officers at ASTRO, RTOG, Gold Medal and other recognized winners at ASTRO, members of National Academy of Sciences, Institutes of Medicine, HHMI Investigators, anyone who *consistently* publishes in NEJM, JAMA, Lancet, Cancer Cell, or Nature Medicine.
 
Members don't see this ad :)
First off, to make things current, maybe we can get rid of Zvi Fuks - since an FBI inditement not only knocks you out of being chair, pretty much does your career a number.

I would add:

Alvaro Martinez (he's a chair-sorry)- Beaumont - Prostate Brachy
Frank Vicini - Beaumont - Partial Breast
James Martinson - Mayo Rochester - GI
Thomas Pisansky - Mayo Rochester - Prostate
Arno Mudnt - Univ Chicago - GU
Joachim Yahalom - MSKCC - Lymphoma
 
I think one of THE biggest name is Sam Hellman at Chicago.
 
stephew said:
CNphair said:
Ted Lawrence-University of Michigan (Chair) GI
Carlos Perez-Washington University (Past-Chair) Gyn
Moody Wharam-hopkins peds and past chair
Louis Constantine-U rochester peds
Richard Stock-Mt Sinai chair GU/Brachy.
Dosortez-was mass gen now private practice
Emami-Loyola (Chair) [Head and Neck]
Zvi Fuks-MSKCC
Steven Leibel-Stanford
Nancy Tarbell - Harvard peds
Sarah Donaldson-Stanford peds
Jay Harris-Harvard
Anthony D'Amico-Harvard GU
Peter Mauch-harvard lymphoma
Patricia Eiffel-MDACC gyne
Norm Coleman-NCI
Nora Janjan
Minesh Metha-University of Wisconsin (Chair) cns
Mark Ritter-u wisc prostate
Jim Welsh-Wisconsin lymphoma, prostate/general, Tomotherapy
Bruce Hafftey-Yale (PD) breast and abr pres
Leonard Proznitz - Duke (former Chair)
Ted DeWeese-Johns Hopkins (Chair) GU
John Flickenger-U Pitt CNS
Susan Woldon-MSKCC peds
Cliff Chao-MDACC H&N
Mendenhall-University of Florida (Chair) H&N
Giles McKenna-U Penn ret. chair
Eli Glatstein-University of Penn (IJROBP Senior Clinical Editor)
William Regine-University of Maryland GI and CNS
Joel Tepper-UNC (Chair) GI
Leonard Gunderson-Mayo Clinic GI
Paul Okunieff-University of Rochester (PD) Chair
Blasko-GU/prostate brachy seattle
Merrick
Mack Roach-UCSF GU
Frank Wilson
James Cox-MDACC (Chair) (IJROBP Editor)
Laurie Gaspar-Univeristy of Colorado (Chair)
Heman Suit-name speaks for itself. ex chair Mas Gen
Mike Zelefsky-GU
A. Zeitman-GU Harvard
Luther Brady
Kian Ang-MDACC H&N
Breizel-H&N
Richard Hoppe - Stanford Lymphoma
Ted Philips-UCSF [Ocular Melanoma]
Bill Shipley-GU Mass Gen
Larry Kun - St.Judes Peds (by definition)
Jay Loeffler-Harvard CNS (benign/protons)
Lou Harrisson
Paul Harari-University of Wisconsin H&N
Phillip Devlin- Harvard Brachytherapy
Akila Viswanathan-Harvard Gyn/Brachy
Tripureneni (Current ASTRO chair)
Phillip Rubin (IJROBP Founding Editor)
J. Martin Brown (IJROBP Bio)
R. Mohan (IJROBP Physics)
L. D. Wilson (IJROBP Critical Review)
Sam Hellman
Peter Glazer - Yale (Chair)
Lori Pierce
Turresi - DMC/Karmanos (Chair)
William Wara - USCF (Chair)
Bruce Minsky
Ten Haken (Physics)
J.A. Purdy
Click to expand...
Click to expand...
 
Ursus Martimus said:
First off, to make things current, maybe we can get rid of Zvi Fuks - since an FBI inditement not only knocks you out of being chair, pretty much does your career a number.
Click to expand...

"Why are you closing us down?"
"I am shocked, shocked to find illegal gambling going on here." "

-- Casablanca.
 
3dtp said:
"Why are you closing us down?"
"I am shocked, shocked to find illegal gambling going on here." "

-- Casablanca.
Click to expand...

(sorry I am a classical music addict), the known musicians are the ones that go on the stage and make CDs etc.

The famed and now deceased Vladimir Horowitz, during his prime time, was very good with Scarlatti and Schumann, but could he beat Alicia De Larrocha with Spanish music? No, De Larrocha is still the "queen" when it comes to Spanish piano music........

That is why Horowitx stayed out of Spanish music during his piano performances.

Now back to the less well known pianists, it does not mean they are no good. Sometimes they are even better than Horowitz or De Larocha but they simply kept quiet doing their work.

Glenn Gould, the famed and now deceased pianist, during the later part of his life, he never performed but recorded alot of musics for CBS.
To this date, no pianists have surpassed than Glenn Gould when it comes to JS Bach interpretation.....Gould's playing is full of precision and discipline, just unbelievable.

Back to our small world of radiation oncology, the less well known is sometimes better.

So radiation oncology is almost (yes almost) like wine, one buys wine because of label....Price does not equal quality.

Drink a wine and if you are happy with it, then it is good wine, regardless of price....
 
you've never heard of my mom but she's one of the best pianists around.
 
medhopeful08 said:
out of curiosity -- who are some of the "big names" in the field of rad onc?
Click to expand...

Stephanie Weiss
 
In regards to the "big names" in Rad Onc, no need to stoke the egos of all the attention-seeking egomaniacs that pervade the field. A lot of Radiation Oncologists stay in the Academic Field because of the status of having a title. Ditto for all the Chairman-for-life individuals. If they truly cared about the best interests of their department, they would voluntarily step down after 6-8 years to allow for a fresh influx of new ideas and perspectives to the department.
 
would you rather have an attention seeking egomaniac in academia or a money grubbing egomaniac treating you?

i am impressed by the quality of doctors in academia...not only are they smart people dedicating their lives to patients, they are also dedicated to research and clinical trials. a lot of private practice docs in many of the fields dont keep in touch with current trends in medicine (radonc included), and only go to conferences to get cme credit.

i know if it were me, or my family member, i would go to a large university setting to receive treatment for elective, outpatient, or serious medical problems.
 
RadOncMan said:
In regards to the "big names" in Rad Onc, no need to stoke the egos of all the attention-seeking egomaniacs that pervade the field. A lot of Radiation Oncologists stay in the Academic Field because of the status of having a title. Ditto for all the Chairman-for-life individuals. If they truly cared about the best interests of their department, they would voluntarily step down after 6-8 years to allow for a fresh influx of new ideas and perspectives to the department.
Click to expand...

Have a care before making this generalization. I know about half a dozen individuals on this list very well, and none of them fit your description. They are all VERY active in, and passionate about, the advancement of cancer care.

Also, I don't believe abdicating the chairmanship is a pre-requisite for the influx of new ideas, although I'd agree having a chair who is OPEN to those ideas is key. Several of the junior faculty here are active researchers in their own right, and are doing a great job of pushing our research efforts in new directions.
 
RadOncMan said:
Try looking at editors of major textbooks, IJROBP, officers at ASTRO, RTOG, Gold Medal and other recognized winners at ASTRO, members of National Academy of Sciences, Institutes of Medicine, HHMI Investigators, anyone who *consistently* publishes in NEJM, JAMA, Lancet, Cancer Cell, or Nature Medicine.
Click to expand...

Yeah I'm a sucker for data:

HHMI: None
NAS: None
Institutes of Medicine:
Allen Lichter (Dean of Medical School & Former Chair, Michigan)
Ted Phillips (UCSF)
Ralph Weischelbaum (Chair, Chicago)
Sarah Donaldson (PD, Stanford)
Saul Rosenberg (Emeritus, Stanford)
Nancy Tarbell (Harvard)
Rakesh Jain (PhD Radiobiology, Harvard)

Consistently publishes in NEJM, JAMA, Lancet, Nature Medicine, or Cancer Cell (or Nature or Science or Cell):

In the last ten years (1996-2006):
AV D'Amico JAMA 1998
WU Shipley JAMA 1999
JS Cooper JAMA 1999
AV D'Amico JAMA 2000
LB Travis JAMA 2003
HP Soares JAMA 2005
AV D'Amico JAMA 2005
AL Zietman JAMA 2005
NN Baxter JAMA 2005
D Halahan Cancer Cell 2003
MW Dewhurst Cancer Cell 2003
RK Jain Cancer Cell 2004
MW Dewhurst Cancer Cell 2005

A Recht NEJM 1996
Swedish Rectal Cancer Trial NEJM 1996
M Bolla NEJM 1997
M Morris NEJM 1999
HM Keys NEJM 1999
A Auperin NEJM 1999
SM Keller NEJM 2000
JS MacDonald NEJM 2001
H Bartelink NEJM 2001
B Fisher NEJM 2002
CH Pui NEJM 2003
KS Hughes NEJM 2004
 
JPaikman said:
Yeah I'm a sucker for data:

HHMI: None
NAS: None
Institutes of Medicine:
Allen Lichter (Dean of Medical School & Former Chair, Michigan)
Ted Phillips (UCSF)
Ralph Weischelbaum (Chair, Chicago)
Sarah Donaldson (PD, Stanford)
Saul Rosenberg (Emeritus, Stanford)
Nancy Tarbell (Harvard)
Rakesh Jain (PhD Radiobiology, Harvard)

Consistently publishes in NEJM, JAMA, Lancet, Nature Medicine, or Cancer Cell (or Nature or Science or Cell):

In the last ten years (1996-2006):
AV D'Amico JAMA 1998
WU Shipley JAMA 1999
JS Cooper JAMA 1999
AV D'Amico JAMA 2000
LB Travis JAMA 2003
HP Soares JAMA 2005
AV D'Amico JAMA 2005
AL Zietman JAMA 2005
NN Baxter JAMA 2005
D Halahan Cancer Cell 2003
MW Dewhurst Cancer Cell 2003
RK Jain Cancer Cell 2004
MW Dewhurst Cancer Cell 2005

(more to be added)
Click to expand...

I'd think consistent publications in the red journal might count at least or more than nature medicine or cancer cell, from a clinician stand point?
 
RadOncMan said:
Much too high overrepresentation of Chairs as well as faculty at big name programs who have nothing behind their CV other than title or affiliation with a big name program.

Try looking at editors of major textbooks, IJROBP, officers at ASTRO, RTOG, Gold Medal and other recognized winners at ASTRO, members of National Academy of Sciences, Institutes of Medicine, HHMI Investigators, anyone who *consistently* publishes in NEJM, JAMA, Lancet, Cancer Cell, or Nature Medicine.
Click to expand...

I would think it a fair measure of a "big name" how active you are contibuting to the field as a whole. With such measure, one can not help to consider how many publications various people have in the field's trade journal, "the red journal". By such criteria many of the names previously listed fail miseably as evidenced below. I would hope the field eventually recognizes contibutes as big names, rather than just people at more prestigious institutions, whom many champion solely for such reasons. I would encourage people to re-evaluate previous lists under such criteria, they may be surprised.

Full length articles in "the red journal" (2004-2005, does not include corrspondences or astro abstract)

Donaldson - 3
D'Amico - 2
Chao - 3
Ang - 18
Harris - 0
Phillips - 0
Tarbell - 6
Tepper - 1
Martinez - 22
 
Ursus Martimus said:
I'd think consistent publications in the red journal might count at least or more than nature medicine or cancer cell, from a clinician stand point?[/QUOTE

3 Comments:
1. Is it really that difficult to publish in the Red Journal, even though it's probably the top subspeciality clinical Radiation Oncology journal? I would think any general interest medical journal, i.e. NEJM, JAMA, Lancet would be much more difficult and include higher impact work.

2. Why is their such a paltry of Radiation Oncologists recognized outside the field? There are 1458 members of the Institutes of Medicine, arguably the most prestigious honorary medical organization, and yet only 7 members who are Radiation Oncologists.

3. I'm not stating that EVERYONE in academia is doing it for ego or status, only that some people are, and it's probably a larger number than you think - particularly in the Radiation Oncology field (because it is such a small field with a proportionately larger number of leadership positions compared with i.e. Internal Medicine). To be sure - there are many reasons why someone would want to stay in academia - interest in teaching, research opportunities, ease of being able to stay current with new developments in the field, availability of use of very expensive cutting edge equipment, ease of obtaining a job at one's own training institution, better job openings in highly saturated markets, i.e. big cities, California compared with private practice. Having a title or affiliation, particularly with a prestigious institution, also probably appeals to a lot of people, though it says nothing about one's contributions to the field. I don't think Chairman are necessarily the best clinicians nor the best investigators - if they were at their prime, they probably wouldn't want the added administrative responsibilities from impeding their research.
A lot of Chairman stay on for too long either because of status, prestige, power, or better pay. A better model would be a rotating chairmanship where new ideas, fresh insights, and renewed energy can much more easily implemented rather than having one "dictatorial" individual define the department.
Click to expand...
 
RadOncMan said:
Is it really that difficult to publish in the Red Journal, even though it's probably the top subspeciality clinical Radiation Oncology journal? I would think any general interest medical journal, i.e. NEJM, JAMA, Lancet would be much more difficult and include higher impact work.
Click to expand...

I would agree, however in such journals, you are more likely to see the results of large muti-institutional trials. I think that more accurately refects the insitutions, as each author is washed out a little.

That might be a tough sell on the argument of how hard it might be to get a paper in the red journal. It even suggests that investigators don't publish in the journal because it is "too easy". I don't get that impression. However a limited authorship paper (say 4-5 contibutors) in Lancet or NEJM is truely to be commended, with perhaps JAMA, less-so.
 
remember last authors often reflect the person who takes the lead in the study (sort of the equivilent of "in my lab" if its clinical) ; if you want to use journals you cant just go by lead author.
 
I think you have to be careful about that 6-8 year rule; Rememebr it takes a couple of years just to begin implimenting the changes of a regime (I've seen it in action unfortunately or fortunately depending upon POV).
 
stephew said:
I think you have to be careful about that 6-8 year rule; Rememebr it takes a couple of years just to begin implimenting the changes of a regime (I've seen it in action unfortunately or fortunately depending upon POV).
Click to expand...

I went by the corresponding author, and actually I'm not sure how to evaluate who gets the "most" credit for large multicentered trials.
 
Does anyone else think that this listing is an exercise in silliness?
 
Butch said:
Does anyone else think that this listing is an exercise in silliness?
Click to expand...

Pretty much, but if you don't exercise your silliness, it will surely atrophy!
 
G'ville Nole said:
Pretty much, but if you don't exercise your silliness, it will surely atrophy!
Click to expand...
Oh I agree this little exercise goes to show the problem with research (or "lies, damned lies and statistics") there is no question about that.

In the meanwhile, the tangent on radonc publications , Ive separated the thread to here:
http://forums.studentdoctor.net/showthread.php?t=249727
 
Well if you all really wanted to get technical, then we should be counting the citation index for each article published and blah blah blah...
but needless to say all the names that are mentioned here are big names in the field.. just to add to this list, why not include all the radiation oncologist on the editorial board of JCO who may or may not have been mentioned :

Edgar Ben-Josef, MD Ann Arbor, MI
David M. Brizel, MD Durham, NC
Hak Choy, MD Dallas, TX
Avraham Eisbruch, MD Ann Arbor, MI
Leonard L. Gunderson, MD, MS Scottsdale, AZ
Larry E. Kun, MD Memphis, TN
Mitchell Machtay, MD Philadelphia, PA
Francoise Mornex, MD Benite, France
Jens Overgaard, MD Aarhus, Denmark
Abram Recht, MD Boston, MA
Edward G. Shaw, MD Winston-Salem, NC
Sharon Spencer, MD Birmingham, AL
Charles R. Thomas Jr, MD San Antonio, TX
Andrew Trotti, MD Tampa, FL
Tim Whelan, BM, BCh, MSc Hamilton, Canada
Christopher Willett, MD Boston, MA
Suzanne L. Wolden, MD New York, NY
Anotheny Zietman, MD Boston, MA
 
You guys are forgetting one of the biggest names of all!

DR. RODNEY WITHERS, ucla

This guy won the Enrico Fermi award for his research in tissue/dose response. His research pretty much set the standard for all rad onc protocol used today. Without him there would be no concept of the "dog-legged" curve or even the concept that dose, and not time between fractions, are what determine long-term effects. Refinements in dose fractionation and hyperfractionation were all from him too!
 
BrachyGuy said:
Can somebody enlist 10 big names in brachytherapy?
Click to expand...

Off the top of my head:

Breast: Doug Arthur (VCU), David Wazer (Tufts), Frank Vicini (Beaumont), Bob Kuske (Ariz. Onc.), Rakesh Patel (Western Rad Onc.), Martin Keisch (Broward)

Prostate: Alvaro Martinez (Beaumont), Richard Stock (Sinai), Jeff Demanes (CA Endocurie), Greg Merrick (WV?), Robert Lee (Wake Forest)

Gyn: Akila Viswanathan (Harvard), Beth Erickson (MCW), Christian Potter (Vienna)
 
Good running list of the academics, but definitely incomplete. Many community-based radiation oncologists have also played very important roles through ASTRO or business. Many people are unaware of the critical role of health policy, etc.

David Beyer
Albert Blumberg
Leslie Botnick
Phillip Devlin
Daniel Dosoretz
Tom Eichler
Wayne Jenkins
Maria Kelly
Bharat Mittal
Louis Potters
Chris Rose
Lee Rogers
Prabhakar Tripuraneni
Terry Wall
Paul Wallner
Tim Williams
Harvey Wolkov

I'm sure that I've missed many others, but don't forget that ASTRO and community radiation oncologists can help tremendously in the success of radiation oncology as a field. Social/political engagement is very important, not just scientific discovery, to the field's success.
 
How do you people find out about all of them? How do you pick out who a "big name" is from someone that is just a good guy (gal) doing good research?
 
You must log in or register to reply here.
Next unread thread

Similar threads

P
Rad Onc oral boards
Replies
10
Views
740
Barcelona PSG
B
Gfunk6
Rad Onc? Burnt Out?
Replies
36
Views
2K
thecarbonionangle
thecarbonionangle
TheWallnerus
Rad onc supervision, the epilogue
Replies
10
Views
1K
elementaryschooleconomics
elementaryschooleconomics
U
Why is rad onc not more competitive?
2 3 4 5
Replies
233
Views
9K
medgator
M
D
Rad onc as a second residency?
Replies
25
Views
2K
SneakyBooger
SneakyBooger
Top